Tele: 561.316.3330
Breaking Medical Device News

Tuesday, September 21, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeDePuy Synthes CompaniesINHANCE™ Shoulder System by DePuy Synthes

INHANCE™ Shoulder System by DePuy Synthes

INHANCE™ Shoulder System

The Johnson & Johnson Medical Devices Companies* announced that DePuy Synthes, The Orthopaedics Company of Johnson & Johnson,** introduces the INHANCE™ Shoulder System, a first-to-market, fully integrated shoulder arthroplasty system.

INHANCE™ Shoulder System is designed with an intuitive stemless-first surgical approach that aligns with how surgeons approach patient care. The INHANCE Shoulder System is the first shoulder system to offer surgeons the ability to seamlessly transition from stemless to stemmed implants during surgical procedures.

There are many reasons surgeons may need to transition to a different surgical treatment option during shoulder arthroplasty procedures, including humeral bone quality and severity of glenoid bone loss, or the extent of rotator cuff deficiency.

The INHANCE Shoulder System empowers surgeons to treat a broad range of cases by providing an intelligently-designed implant offering that is both streamlined and comprehensive, and also features unique interoperative flexibility, addressing a critical unmet clinical need. The common instrumentation of the INHANCE Shoulder System also facilitates greater OR efficiency1.

This new class of shoulder system also features:

  • Reusable instrumentation optimized for efficiency with only two instrument cases for stemless and stemmed anatomic procedures
  • A comprehensive size range of anatomic stemless and stemmed inlay humeral implants that share a common geometrical shape to easily fixate to the humerus
  • A unique circular anatomic glenoid component compatible with any sized humeral head, and the ONE STEP PREP™ Glenoid Reamer that reduces the number of surgical steps, eliminating the need to separately ream the backside of the implant, drill the central hole, and drill the peripheral holes2

“Advancements in shoulder arthroplasty have enabled a broader range of surgical treatment over the past decade but have increased the complexity and cost of preparing for each surgical case,” said J. Michael Wiater, MD, Vice Chairman, Chief of Shoulder Surgery and Professor of Orthopedic Surgery, Oakland University William Beaumont School of Medicine***. “The INHANCE™ Shoulder System can empower surgeons to seamlessly alter their surgical flow, while simultaneously keeping their focus on the patient, and has the potential to reduce OR time.”

The INHANCE™ Shoulder System is also designed for the shift in site of care of certain orthopaedic procedures towards outpatient and ambulatory surgery centers where economic value and operational efficiency are critical considerations. The INHANCE Shoulder System’s implants are designed to preserve bone, provide immediate and long-term fixation, and facilitate intra-operative flexibility while simplifying preparation for various surgical treatment options3,4.

Additional features of the system include:

  • Novel implant designs that are additively manufactured via state-of-the-art 3D laser printing incorporating the UNITI™ Porous Structure, which was created specifically for biological fixation in the shoulder.3
  • Only two reusable instrument cases are required, reducing the number of trays needed to be reprocessed, stored, and retrieved
  • Advanced cross-linked Vitamin E polyethylene for desired wear characteristics and oxidative stability, which becomes an important consideration to reduce the risk of revision and complications4, which can potentially reduce the economic burden to the healthcare system.

DePuy Synthes acquired the INHANCE™ Shoulder System through a multi-year, strategic agreement with Ignite Orthopedics, LLC. Through this collaboration, DePuy Synthes will launch the core system plus additional product innovations. The INHANCE Shoulder System was designed in collaboration with a team of leading shoulder arthroplasty surgeons and is competitively positioned to address the increasing complexity of shoulder replacement procedures by integrating less invasive clinical options aligned with how surgeons approach patient care.

“At DePuy Synthes we’re focused on delivering innovations to address the most pressing needs of surgeons today while anticipating market dynamics that drive clinical trends and the needs of tomorrow,” said Russell Powers, Worldwide President, Sports Medicine and Shoulder Reconstruction, DePuy Synthes****. “The INHANCE™ Shoulder System reflects our strong commitment to lead in shoulder arthroplasty by taking innovation to the next level.”


References

1 INHANCE Surgical Step Comparison (Glenoid and Humeral) DPS – 103814569 Rev 1 and DPS – 103814569. See document summary tab.

2 INHANCE Surgical Step Comparison DPS 103814569 Rev 1 -. See document summary tab.

3 Ignite TR-200803 REV 00 – X1 Fine 3D Printed Porous Eval Including Appendix’s’ A thru E

4 Ignite Characterization of AO-HXLPE Report

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

FDA Authorizes Software that Can Help Identify Prostate Cancer

The software is called Paige Prostate and is compatible for use with slide images that have been digitized using a scanner.

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

By using this website you agree to accept Medical Device News Magazine Privacy Policy